Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
- Resource Type
- article
- Source
- Genes and Diseases, Vol 11, Iss 2, Pp 550-553 (2024)
- Subject
Medicine (General) R5-920 Genetics QH426-470 - Language
- English
- ISSN
- 2352-3042